SE0201940D0 - New combination II - Google Patents

New combination II

Info

Publication number
SE0201940D0
SE0201940D0 SE0201940A SE0201940A SE0201940D0 SE 0201940 D0 SE0201940 D0 SE 0201940D0 SE 0201940 A SE0201940 A SE 0201940A SE 0201940 A SE0201940 A SE 0201940A SE 0201940 D0 SE0201940 D0 SE 0201940D0
Authority
SE
Sweden
Prior art keywords
new combination
relates
disease
reflux
thrive
Prior art date
Application number
SE0201940A
Other languages
English (en)
Inventor
Anders Lehmann
Michael Wrangstadh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201940A priority Critical patent/SE0201940D0/sv
Publication of SE0201940D0 publication Critical patent/SE0201940D0/sv
Priority to ARP030102095A priority patent/AR040203A1/es
Priority to TW092116257A priority patent/TW200403059A/zh
Priority to PCT/SE2003/001008 priority patent/WO2004000856A1/en
Priority to AU2003237739A priority patent/AU2003237739A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof
SE0201940A 2002-06-20 2002-06-20 New combination II SE0201940D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II
ARP030102095A AR040203A1 (es) 2002-06-20 2003-06-11 Combinacion de un inhibidor del reflujo y una imidazopiridina para el tratamiento de la gerd
TW092116257A TW200403059A (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
PCT/SE2003/001008 WO2004000856A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
AU2003237739A AU2003237739A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II

Publications (1)

Publication Number Publication Date
SE0201940D0 true SE0201940D0 (sv) 2002-06-20

Family

ID=20288298

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II

Country Status (5)

Country Link
AR (1) AR040203A1 (sv)
AU (1) AU2003237739A1 (sv)
SE (1) SE0201940D0 (sv)
TW (1) TW200403059A (sv)
WO (1) WO2004000856A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315862C (zh) 2000-05-26 2007-05-16 艾登尼科斯（开曼）有限公司 处理黄病毒和瘟病毒的方法和组合物
EP1644043A1 (en) * 2003-05-27 2006-04-12 ALTANA Pharma AG Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
WO2006050471A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531510B1 (en) 2010-02-01 2014-07-23 Novartis AG Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
US8546416B2 (en) 2011-05-27 2013-10-01 Novartis Ag 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
PE20142443A1 (es) 2012-05-03 2015-01-28 Novartis Ag Sal de l-malato de derivados de 2,7-diaza-espiro[4,5]dec-7-ilo y formas cristalinas de los mismos como agonistas del receptor de grelina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
TW200403059A (en) 2004-03-01
AU2003237739A1 (en) 2004-01-06
AR040203A1 (es) 2005-03-16
WO2004000856A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
SE0201940D0 (sv) New combination II
ATE408601T1 (de) Fredericamycin-derivate
DE602004026113D1 (de) Glp-1-verbindungen
CY1109240T1 (el) Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
NO20052591L (no) Pyridopyrolizin og pyridoindolizinderivater
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
EA200500715A1 (ru) Новые лекарственные средства для лечения хронического обструктивного заболевания лёгких
RS52942B (en) TREATMENT OF TYPE 2 DIABETES BY THE COMBINATION OF DPIV IHIBITORS AND METFORMIN OR THIAZOLIDINDION
NO20052512L (no) Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
CY1110669T1 (el) Χρησιμοποιηση βενζο-συγχωνευμενων ετεροκυκλικων παραγωγων σουλφαμιδιου για τη θεραπευτικη αγωγη της καταθλιψης
SE0301888D0 (sv) New use VII
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
HRP20050439B1 (en) New use of dextran sulfate
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
SE0101932D0 (sv) Pharmaceutical combinations
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20043115L (no) Substituerte diketopiperaziner som oksytocin antagonister
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)